Titan Biotech Ltd Price Performance
- Day's Low
- ₹0
- Day's High
- ₹0
₹ 0
- 52-w low
- ₹0
- 52-w high
- ₹0
0
- Day's open
₹0 - Previous close
₹0 - VWAP
₹0 - Lower price band
₹0 - Upper price band
₹0
Today's Market Action
Its last traded stock price on BSE was 470.00 down by -2.45%. The total volume of shares on NSE and BSE combined was 14,025 shares. Its total combined turnover was Rs 0.66 crores.
Titan Biotech Ltd Medium and Long Term Market Action
The stock price of Titan Biotech Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.
Titan Biotech Ltd Fundamentals
-
Market Cap (Cr): 398
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Titan Biotech Ltd Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About Titan Biotech Ltd
Data not available.
Titan Biotech Ltd FAQ's
What is Share Price of Titan Biotech Ltd?
What is the Market Cap of Titan Biotech Ltd?
What is PE Ratio of Titan Biotech Ltd?
What is PB Ratio of Titan Biotech Ltd?
What is the CAGR of Titan Biotech Ltd?
How to Buy Titan Biotech Ltd Share?
Financials
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
News
Review
Pros
Above Average Sustainable RoE
High Pricing Power
Zero Debt
Above Average Growth Rate
Cons
Low Return on Capital Employed
Highly Cyclical Industry
Poor Working Capital Cycle
Poor Corporate Governance
Valuation Analysis
Margin of safety
(25/03/2025)
(25/03/2025)


107
100.00% People are bullish about Titan Biotech Ltd
0.00 % People are bearish about Titan Biotech Ltd